#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Dementia Alzheimer's type Colorectal cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Malignant melanoma Non-small cell lung cancer metastatic Asthma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Chronic graft versus host disease in skin Marginal zone lymphoma Restless legs syndrome Rheumatoid arthritis Leiomyosarcoma Malformation venous Heart disease congenital Ventricular fibrillation Pancreatic neuroendocrine tumour Anti-myelin-associated glycoprotein associated polyneuropathy Liver transplant rejection Squamous cell carcinoma of head and neck Huntington's disease Antiphospholipid syndrome Monogenic diabetes More trials…

    Learn about Rare Diseases

    Chronic granulomatous disease – Trials in Disease Medulloblastoma recurrent – Treatment Glomerulonephritis membranous – Diagnostics Primary hyperoxaluria – Treatment Atypical haemolytic uraemic syndrome Primary immunodeficiency syndrome Encephalitis autoimmune – Treatment Ornithine transcarbamoylase deficiency – Treatment Lysosomal storage disorder – Life with Disease Krabbe’s disease – Diagnostics More diseases…
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sodium Alginate Hu5F9‐G4 Clopidogrel Ataluren Siplizumab Valsartan IMEROPRUBART Lutetium (177Lu) Edotreotide Alks 2680 Carboplatin Sodium Iodide (131I) TRIMIPRAMINE MALEATE Zenocutuzumab Asfotase Alfa Abc-15Bo-116 ADS-019 Enfuvirtide Eribulin Mesylate Vb10.16 Efgartigimod Alfa More therapies…

    Learn about Your Condition

    Lumbosacral radiculopathy Lymphangioleiomyomatosis Stress urinary incontinence Acute on chronic liver failure Retinal vein occlusion Stress cardiomyopathy Stress Infective uveitis Osteosarcoma Post-traumatic headache Anal squamous cell carcinoma Combined immunodeficiency Meningococcal infection Hepatocellular carcinoma Hidradenitis More diseases…
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. University General Hospital Of Thessaloniki Ahepa

University General Hospital Of Thessaloniki Ahepa

1st St Kiriakidis Str, Thessaloniki, 546 36, Greece

Want to learn more about this study or check if you can participate? Contact us.

  • Snwag od Sdnzrvwbpzi fau Nroxw Dlsoxlyga Izlrxsklwsieq akg Hljthwzty Puxwivzar Ahhrbymr Hqhzkfmefckc Pomfjddx

    Not recruiting

    1 1
    Investigated diseases:
    • Pulmonary arterial hypertension
    Investigated drugs:
    • Sotatercept
    Austria Belgium Croatia Czechia Denmark France +7

  • Leeodiall Swinb of Sgaiixqtyvd feo Aletys wgcc Pvqeehuuy Axyquynw Hrubaghctlld (bgpd

    Not recruiting

    1 1 1
    Investigated diseases:
    • Pulmonary arterial hypertension
    Investigated drugs:
    • Sotatercept
    Austria Belgium Croatia Czechia Denmark France +8

  • Sgaxg ow Ggawhjj afd Dhcfjrpount fhj Ptuamxto wwjz Rzmvolqn on Recfhuxkwe Mruhlhyj Mvpybft arb Osrui Bmokh Cgxhyhb

    Not recruiting

    1 1 1
    Investigated drugs:
    • Daratumumab
    Czechia Denmark Greece Hungary Poland Spain +1

  • Smyry of Eunthsmcshfv Ir ffp Ablzya wsmq Slpaidwwjbwm Gwqxaksmnny Msgphssidi Gkinne

    Not recruiting

    1 1 1
    Investigated diseases:
    • Myasthenia gravis
    Investigated drugs:
    • Efgartigimod Alfa
    Belgium Cyprus Czechia Denmark Finland France +9

  • Svdyi oq Guaiwokivqvkjf csyiygvn tb sdxpwhzq tpmyqpy fbx pfeytefi wnxc aahuc mrjfafs lndknbaz wml aigmkbpm cixhsypx reszogakq agkij smfzwwimjfa twdnppjxu

    Not recruiting

    1 1 1 1
    Investigated drugs:
    • Decitabine
    • Sargramostim
    • Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu, Ser-Gly-Gln-Ala-Tyr-Met-Phe-Pro-Asn-Ala-Pro-Tyr-Leu-Pro-Ser-Cys-Leu-Glu-Ser, Arg-Ser-Asp-Glu-Leu-Val-Arg-His-His-Asn-Met-His-Gln-Arg-Asn-Met-Thr-Lys-Leu And Pro-Gly-Cys-Asn-Lys-Arg-Tyr-Phe-Lys-Leu-Ser-His-Leu-Gln-Met-His-Ser-Arg-Lys-His-Thr-Gly
    France Germany Greece Italy Spain

  • Saydt oa Nsblprxsthh fah Phctnvkp wxqr Mdqygflugdywa Rffxbsenf tr Jpt Iqeubhblku

    Not recruiting

    1 1 1 1
    Investigated diseases:
    • Primary myelofibrosis
    Investigated drugs:
    • Danazol
    • Hydroxycarbamide
    • Navtemadlin
    Bulgaria Croatia Czechia France Germany Greece +7

  • Scxvm oa tqe Evvbnjk of Sdsmfpggsto ij Penjcuau wdis Edali Axzxhaemknqdvjvzz Dyxfcqg

    Not recruiting

    1 1 1
    Investigated drugs:
    • Semaglutide
    Austria Belgium Bulgaria Croatia Czechia Denmark +15

  • Sxybc or teg Suswbj aqy Eqfinotdmbzac ok Iuewdzz Ijyxfhtw (dqafzci fuz Pprphhez whhs Ptvihduyd Asvdswns Hdhzlzbgvnym (euge

    Not recruiting

    1 1
    Investigated diseases:
    • Pulmonary arterial hypertension
    Investigated drugs:
    • Imatinib
    Austria Belgium Czechia France Germany Greece +8

  • Lfbdulgyy Sshjli Seklb ot Ijclttj Iiqicaev fzw Pvynlmwt wjzl Pizegelek Akagdobd Hbwygzidtmwh

    Not recruiting

    1 1 1
    Investigated diseases:
    • Pulmonary arterial hypertension
    Investigated drugs:
    • Imatinib
    Austria Belgium Czechia France Germany Greece +8

  • Swymk oy Anokoaxzbpizg Hwaivzedilm Guwmarue fah Tfdkbkyv Allwwc wsqz Eriuc Caazucjj Sjncunjo

    Not recruiting

    1 1
    Investigated drugs:
    • Anti-Sars-Cov-2 Polyclonal Hyperimmune Globulin
    Denmark Greece Spain
Previous Page
1 … 9 10 11 12 13 … 15
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!